Summary & Overview
CPT 67228: Photocoagulation Treatment for Extensive Retinopathy
CPT code 67228 represents photocoagulation treatment for extensive or progressive retinopathy, most commonly associated with diabetic retinopathy. This procedure is a cornerstone in ophthalmology for preventing vision loss in patients with advanced retinal disease. The code is widely recognized and reimbursed by major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare.
This publication provides a comprehensive overview of 67228, covering payer coverage, clinical context, and relevant billing benchmarks. Readers will gain insight into the procedure's role in retinal disease management, typical sites of service, and the importance of accurate coding for reimbursement. Policy updates and clinical guidelines related to photocoagulation are also discussed, along with comparisons to related CPT codes. The summary includes information on common modifiers and associated provider taxonomies, offering a clear understanding of how this code is utilized in practice.
Healthcare professionals, billing specialists, and policy analysts will find this resource valuable for understanding national trends, payer policies, and clinical applications of 67228. The publication is designed to support informed decision-making and ensure compliance with current standards in ophthalmology billing and coding.
CPT Code Overview
CPT code 67228 is used for the treatment of extensive or progressive retinopathy, such as diabetic retinopathy, through photocoagulation. This procedure falls under the ophthalmology service type and is typically performed in an office setting (Place of Service 11). Photocoagulation is a laser treatment aimed at preventing further vision loss by targeting damaged areas of the retina. The code is essential for documenting and billing this advanced retinal intervention, which is a critical component in the management of patients with progressive retinal diseases.
Clinical & Coding Specifications
Clinical Context
A patient with diabetes mellitus presents to the ophthalmology office for evaluation of vision changes. On examination and diagnostic imaging, the provider identifies extensive or progressive diabetic retinopathy without macular edema. The patient is scheduled for photocoagulation treatment to prevent further retinal damage and vision loss. The procedure is performed in the office setting by an ophthalmologist or retina specialist, targeting affected areas of the retina using laser therapy. Post-procedure, the patient is monitored for response and potential complications, with follow-up visits to assess retinal status and disease progression.
Coding Specifications
-
Modifiers:
LT: Indicates the procedure was performed on the left eye.RT: Indicates the procedure was performed on the right eye.50: Indicates the procedure was performed bilaterally on both eyes.
-
Provider Taxonomies:
Taxonomy Code Specialty Name 207W00000XOphthalmology 207WX0009XRetina Specialist 207WX0107XUveitis and Ocular Inflammatory Disease Specialist
These taxonomies represent providers specializing in eye care, retinal diseases, and ocular inflammatory conditions.
Related Diagnoses
-
E11.319: Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema- Relevant for patients with diabetic retinopathy undergoing photocoagulation without macular involvement.
-
H35.81: Retinal edema- Indicates retinal swelling, which may be present in patients requiring photocoagulation.
-
H35.00: Background retinopathy, unspecified- Used for patients with early or unspecified retinopathy, potentially progressing to require treatment.
-
H35.89: Other specified retinal disorders- Covers other retinal conditions that may necessitate photocoagulation.
-
E10.319: Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema- Relevant for patients with type 1 diabetes and retinopathy, similar to
E11.319.
- Relevant for patients with type 1 diabetes and retinopathy, similar to
Related CPT Codes
| CPT Code | Description | Clinical Relationship |
|---|---|---|
67210 | Destruction of localized lesion of retina | Used for treating localized retinal lesions; alternative to 67228 for less extensive disease |
67220 | Destruction of localized lesion of choroid | Used for treating choroidal lesions; not specific to retinopathy but may be performed in similar clinical scenarios |
67227 | Destruction of extensive or progressive retinopathy, one or more sessions | Similar to 67228; may be used for multiple sessions or as an alternative code depending on clinical documentation |
92134 | Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina | Commonly used for diagnostic imaging before or after photocoagulation procedures to assess retinal status |
Codes 67210, 67220, and 67227 may be used as alternatives depending on the extent and location of disease. Code 92134 is often used in conjunction with 67228 for diagnostic purposes.
National Reimbursement Benchmarks
National mean rates for CPT code 67228 show that Medicare reimburses at $352.22, while the BUCA (Blue Cross Blue Shield, UnitedHealth Group, Cigna, and Aetna) commercial average is significantly higher at $605.26. Among individual commercial payers, Cigna and UnitedHealth Group have the highest mean rates, both above $729.
Rate dispersion varies notably across payers. Medicare has the tightest range, with a difference of $31.00 between the 75th and 25th percentiles, indicating relatively consistent reimbursement. In contrast, Cigna exhibits the widest spread, with a $525.35 difference between its 75th and 25th percentiles, reflecting substantial variability in commercial rates. Blue Cross Blue Shield and UnitedHealth Group also show wide ranges, while Aetna and BUCA are moderately dispersed.
The table and chart below present the full breakdown of national benchmarks for each payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.